203 related articles for article (PubMed ID: 32795579)
1. Low molecular weight heparin modified bone targeting liposomes for orthotopic osteosarcoma and breast cancer bone metastatic tumors.
Wu H; Luo Y; Xu D; Ke X; Ci T
Int J Biol Macromol; 2020 Dec; 164():2583-2597. PubMed ID: 32795579
[TBL] [Abstract][Full Text] [Related]
2. Engineering of Bone- and CD44-Dual-Targeting Redox-Sensitive Liposomes for the Treatment of Orthotopic Osteosarcoma.
Feng S; Wu ZX; Zhao Z; Liu J; Sun K; Guo C; Wang H; Wu Z
ACS Appl Mater Interfaces; 2019 Feb; 11(7):7357-7368. PubMed ID: 30682240
[TBL] [Abstract][Full Text] [Related]
3. Low molecular weight heparin-based reduction-sensitive nanoparticles for antitumor and anti-metastasis of orthotopic breast cancer.
Sun H; Cao D; Liu Y; Wang H; Ke X; Ci T
Biomater Sci; 2018 Jul; 6(8):2172-2188. PubMed ID: 29942949
[TBL] [Abstract][Full Text] [Related]
4. Doxorubicin-poly (ethylene glycol)-alendronate self-assembled micelles for targeted therapy of bone metastatic cancer.
Ye WL; Zhao YP; Li HQ; Na R; Li F; Mei QB; Zhao MG; Zhou SY
Sci Rep; 2015 Sep; 5():14614. PubMed ID: 26419507
[TBL] [Abstract][Full Text] [Related]
5. Bisphosphonate-functionalized coordination polymer nanoparticles for the treatment of bone metastatic breast cancer.
He Y; Huang Y; Huang Z; Jiang Y; Sun X; Shen Y; Chu W; Zhao C
J Control Release; 2017 Oct; 264():76-88. PubMed ID: 28842315
[TBL] [Abstract][Full Text] [Related]
6. Development of low molecular weight heparin based nanoparticles for metastatic breast cancer therapy.
Sun H; Cao D; Wu H; Liu H; Ke X; Ci T
Int J Biol Macromol; 2018 Jun; 112():343-355. PubMed ID: 29409771
[TBL] [Abstract][Full Text] [Related]
7. Heparin modified photosensitizer-loaded liposomes for tumor treatment and alleviating metastasis in phototherapy.
Cao D; Li H; Luo Y; Feng N; Ci T
Int J Biol Macromol; 2021 Jan; 168():526-536. PubMed ID: 33310104
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of Cancer Chemotherapeutic Efficacy via Bone-Targeted Drug Delivery Carrier in Bone Metastases.
Xue X; Yu J; Lu F; Jiang H; Wang X
Drug Des Devel Ther; 2021; 15():4455-4468. PubMed ID: 34737552
[TBL] [Abstract][Full Text] [Related]
9. Estrogen-functionalized liposomes grafted with glutathione-responsive sheddable chotooligosaccharides for the therapy of osteosarcoma.
Yin X; Feng S; Chi Y; Liu J; Sun K; Guo C; Wu Z
Drug Deliv; 2018 Nov; 25(1):900-908. PubMed ID: 29644882
[TBL] [Abstract][Full Text] [Related]
10. Low Molecular Weight Heparin-Coated and Dendrimer-Based Core-Shell Nanoplatform with Enhanced Immune Activation and Multiple Anti-Metastatic Effects for Melanoma Treatment.
Xia C; Yin S; Xu S; Ran G; Deng M; Mei L; Tang X; Rao J; Li M; Zhang Z; He Q
Theranostics; 2019; 9(2):337-354. PubMed ID: 30809278
[TBL] [Abstract][Full Text] [Related]
11. Osteotropic therapy via targeted layer-by-layer nanoparticles.
Morton SW; Shah NJ; Quadir MA; Deng ZJ; Poon Z; Hammond PT
Adv Healthc Mater; 2014 Jun; 3(6):867-75. PubMed ID: 24124132
[TBL] [Abstract][Full Text] [Related]
12. Alendronate coated poly-lactic-co-glycolic acid (PLGA) nanoparticles for active targeting of metastatic breast cancer.
Thamake SI; Raut SL; Gryczynski Z; Ranjan AP; Vishwanatha JK
Biomaterials; 2012 Oct; 33(29):7164-73. PubMed ID: 22795543
[TBL] [Abstract][Full Text] [Related]
13. Antiangiogenic antitumor activity of HPMA copolymer-paclitaxel-alendronate conjugate on breast cancer bone metastasis mouse model.
Miller K; Eldar-Boock A; Polyak D; Segal E; Benayoun L; Shaked Y; Satchi-Fainaro R
Mol Pharm; 2011 Aug; 8(4):1052-62. PubMed ID: 21545170
[TBL] [Abstract][Full Text] [Related]
14. Redox and pH dual sensitive bone targeting nanoparticles to treat breast cancer bone metastases and inhibit bone resorption.
Zhao YP; Ye WL; Liu DZ; Cui H; Cheng Y; Liu M; Zhang BL; Mei QB; Zhou SY
Nanoscale; 2017 May; 9(19):6264-6277. PubMed ID: 28470315
[TBL] [Abstract][Full Text] [Related]
15. Poly(ethylene glycol)-paclitaxel-alendronate self-assembled micelles for the targeted treatment of breast cancer bone metastases.
Miller K; Clementi C; Polyak D; Eldar-Boock A; Benayoun L; Barshack I; Shaked Y; Pasut G; Satchi-Fainaro R
Biomaterials; 2013 May; 34(15):3795-806. PubMed ID: 23434349
[TBL] [Abstract][Full Text] [Related]
16. Dendritic poly(ethylene glycol) bearing paclitaxel and alendronate for targeting bone neoplasms.
Clementi C; Miller K; Mero A; Satchi-Fainaro R; Pasut G
Mol Pharm; 2011 Aug; 8(4):1063-72. PubMed ID: 21608527
[TBL] [Abstract][Full Text] [Related]
17. Redox-sensitive and hyaluronic acid functionalized liposomes for cytoplasmic drug delivery to osteosarcoma in animal models.
Chi Y; Yin X; Sun K; Feng S; Liu J; Chen D; Guo C; Wu Z
J Control Release; 2017 Sep; 261():113-125. PubMed ID: 28666726
[TBL] [Abstract][Full Text] [Related]
18. Hyaluronated liposomes containing H2S-releasing doxorubicin are effective against P-glycoprotein-positive/doxorubicin-resistant osteosarcoma cells and xenografts.
Gazzano E; Buondonno I; Marengo A; Rolando B; Chegaev K; Kopecka J; Saponara S; Sorge M; Hattinger CM; Gasco A; Fruttero R; Brancaccio M; Serra M; Stella B; Fattal E; Arpicco S; Riganti C
Cancer Lett; 2019 Aug; 456():29-39. PubMed ID: 31047947
[TBL] [Abstract][Full Text] [Related]
19. Co-nanoencapsulated doxorubicin and Dz13 control osteosarcoma progression in a murine model.
Tan ML; Friedhuber AM; Dass CR
J Pharm Pharmacol; 2013 Jan; 65(1):35-43. PubMed ID: 23215686
[TBL] [Abstract][Full Text] [Related]
20. Calcium phosphate nanoparticles functionalized with alendronate-conjugated polyethylene glycol (PEG) for the treatment of bone metastasis.
Chu W; Huang Y; Yang C; Liao Y; Zhang X; Yan M; Cui S; Zhao C
Int J Pharm; 2017 Jan; 516(1-2):352-363. PubMed ID: 27887884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
